The Ever-Changing Standards of Cgmp: United States V. Barr Laboratories, Inc
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Clinical Research and Regulatory Affairs
- Vol. 10 (3) , 137-157
- https://doi.org/10.3109/10601339309014394
Abstract
Each day with confidence and hope millions of people in the United States and other countries reach for pills, powders, capsules and syrups to relieve or prevent an infinite number of physical and mental ailments. The weighty task of ensuring the integrity of these products, frequently unquestioned by most consumers, falls to the Food and Drug Administration, which monitors the practices of the drug industry through a system of approvals and investigations. Built into this maze of often ambiguous rules, however, is the recognition that drug manufacturers are businesses, which must follow efficient as well as effective procedures.Keywords
This publication has 0 references indexed in Scilit: